Department of Chemistry, Indian Institute of Technology Bombay, Maharashtra, India.
J Biomol Struct Dyn. 2023 Jun;41(9):3728-3740. doi: 10.1080/07391102.2022.2054472. Epub 2022 Mar 28.
Insights into drug-DNA interactions have importance in medicinal chemistry as it has a major role in the evolution of new therapeutic drugs. Therefore, binding studies of small molecules with DNA are of significant interest. Spectroscopy, coupled with measurements of viscosity and molecular docking studies were employed to obtain mechanistic insights into the binding of altretamine with calf thymus DNA (CT-DNA). The UV-visible spectroscopic measurements study confirmed altretamine-CT-DNA complex formation with affinity constant ([15.68 ± 0.04] × 10 M), a value associated with groove binding phenomenon. The associated thermodynamic signatures suggest enthalpically driven interactions. The values of standard molar free energy change () -(23.93 ± 0.23) kJ mol, enthalpy change () -(50.84 ± 0.19) kJ mol and entropy change () -(90.29 ± 0.12) JK mol indicate the binding is thermodynamically favorable and an important role of the hydrogen bonds and Van der Waals interactions in the binding of altretamine with CT-DNA. Circular dichroism spectroscopy indicated insignificant conformational changes in the DNA backbone upon interaction with altretamine suggesting no distortion and/or unstacking of the base pairs in the DNA helix. UV-melting study suggested that the thermal stability of the DNA backbone is not affected by the binding of the drug. Competitive displacement assays with ethidium bromide, Hoechst-33258 and DAPI established the binding of altretamine with CT-DNA in the minor groove. The mode of binding was further confirmed by viscosity and molecular docking studies. Molecular docking further ascertained binding of altretamine in the minor groove of the CT-DNA, preferably with the A-T rich sequences.[Formula: see text]HighlightsAltretamine binds CT-DNA which is enthalpically driven with K of the order of 10Insignificant conformational change is observed due to DNA-altretamine complexationAltretamine binds favorably with A-T rich sequences in the minor groove of CT-DNAMechanistic insights obtained based on thermodynamic signaturesCommunicated by Ramaswamy H. Sarma.
药物与 DNA 的相互作用在药物化学中具有重要意义,因为它在新治疗药物的发展中起着重要作用。因此,小分子与 DNA 的结合研究具有重要意义。采用光谱法、粘度测量和分子对接研究,获得了三嗪类抗肿瘤药物六甲蜜胺与小牛胸腺 DNA(CT-DNA)结合的机制见解。紫外可见光谱测量研究证实了六甲蜜胺与 CT-DNA 的复合物形成,其亲和常数为[15.68 ± 0.04]×10 M,这与沟结合现象有关。相关热力学特征表明,相互作用是焓驱动的。标准摩尔自由能变化 () 的值为-(23.93 ± 0.23) kJ mol,焓变 () 的值为-(50.84 ± 0.19) kJ mol,熵变 () 的值为-(90.29 ± 0.12) JK mol,表明结合是热力学有利的,氢键和范德华相互作用在六甲蜜胺与 CT-DNA 的结合中起着重要作用。圆二色性光谱表明,DNA 骨架在与六甲蜜胺相互作用后没有发生显著的构象变化,这表明 DNA 螺旋中的碱基对没有扭曲和/或解堆叠。紫外熔融研究表明,药物结合不会影响 DNA 骨架的热稳定性。与溴化乙锭、Hoechst-33258 和 DAPI 的竞争性置换实验证实了六甲蜜胺与 CT-DNA 在小沟中的结合。通过粘度和分子对接研究进一步证实了结合模式。分子对接进一步证实了六甲蜜胺与 CT-DNA 的小沟结合,特别是与富含 A-T 的序列结合。[公式:见文本]要点六甲蜜胺与 CT-DNA 结合,其 K 值在 10 左右,是焓驱动的。观察到由于 DNA-六甲蜜胺复合物的形成,构象变化不明显。六甲蜜胺与 CT-DNA 小沟中富含 A-T 的序列结合良好。基于热力学特征获得的机制见解。由 Ramaswamy H. Sarma 传达。